Viz.ai, an AI-powered disease detection and care coordination platform, has raised a USD100 million in a Series D funding round at a USD1.2 billion valuation.
The round, which comes as the number of hospitals using the Viz Platform surpasses the 1,000 mark and patients served reaches millions, was led by Tiger Global and Insight Partners.
Also joining the round were several of the company’s early backers, including Scale Ventures, Kleiner Perkins, Threshold, GV (formerly Google Ventures), Sozo Ventures, CRV, and Susa. The new funds will be used to support Viz.ai’s significant growth trajectory, expand the Viz Platform to detect and triage additional diseases, and grow its customer base globally.
